Hepatitis G vírus infekció vesetranszplantált és dializált gyermek és felnött betegekben.

Translated title of the contribution: Hepatitis G virus infection in hemodialyzed children and adults following kidney transplantation

A. Szabó, U. Heemann, V. Müller, G. Reusz, P. Sallay, S. Viazov, T. Tulassay

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Recently, a new human virus hepatitis G virus was identified. The aim of the present study was to use a combination of the reverse transcription-polymerase chain reaction and a new test for antibodies to the viral envelope protein E2 to assess the prevalence of hepatitis G virus infection in sera of children and adults treated with hemodialysis or peritoneal dialysis as well as in sera of those who underwent renal transplantation. Hepatitis G virus RNA prevalence was higher in the shole group of patients with renal failure than in control group. The difference between hepatitis RNA prevalence in transplanted group and in control group was found to be significant. Anti-E2, which are is considered as an indicator of a past hepatitis G virus infection, were detected in the similar rate in the treated and control subjects. Time on hemodialysis was significantly longer in hepatitis G virus infected patients as compared to uninfected patients and all patients with hepatitis G virus RNA have a history of blood transfusions. Patients with renal failure treated with dialysis or subjected to renal transplantation are at increased risk of acquiring the hepatitis G virus infection. Higher rates of the hepatitis G virus RNA and similar prevalence of anti-E2 in patients with renal failure as compared to controls suggest that the rate of hepatitis G virus infection resolution in immunosuppressed patients with renal failure might be lower than in immunocompetent subjects.

Original languageHungarian
Pages (from-to)1619-1623
Number of pages5
JournalOrvosi Hetilap
Volume140
Issue number29
Publication statusPublished - Jul 18 1999

Fingerprint

GB virus C
Virus Diseases
Kidney Transplantation
Renal Insufficiency
RNA
Renal Dialysis
Viral Envelope Proteins
Control Groups
Peritoneal Dialysis
Serum
Blood Transfusion
Hepatitis
Reverse Transcription
Dialysis
Viruses

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hepatitis G vírus infekció vesetranszplantált és dializált gyermek és felnött betegekben. / Szabó, A.; Heemann, U.; Müller, V.; Reusz, G.; Sallay, P.; Viazov, S.; Tulassay, T.

In: Orvosi Hetilap, Vol. 140, No. 29, 18.07.1999, p. 1619-1623.

Research output: Contribution to journalArticle

@article{f21a0a9243e54031962f9864b75262f3,
title = "Hepatitis G v{\'i}rus infekci{\'o} vesetranszplant{\'a}lt {\'e}s dializ{\'a}lt gyermek {\'e}s feln{\"o}tt betegekben.",
abstract = "Recently, a new human virus hepatitis G virus was identified. The aim of the present study was to use a combination of the reverse transcription-polymerase chain reaction and a new test for antibodies to the viral envelope protein E2 to assess the prevalence of hepatitis G virus infection in sera of children and adults treated with hemodialysis or peritoneal dialysis as well as in sera of those who underwent renal transplantation. Hepatitis G virus RNA prevalence was higher in the shole group of patients with renal failure than in control group. The difference between hepatitis RNA prevalence in transplanted group and in control group was found to be significant. Anti-E2, which are is considered as an indicator of a past hepatitis G virus infection, were detected in the similar rate in the treated and control subjects. Time on hemodialysis was significantly longer in hepatitis G virus infected patients as compared to uninfected patients and all patients with hepatitis G virus RNA have a history of blood transfusions. Patients with renal failure treated with dialysis or subjected to renal transplantation are at increased risk of acquiring the hepatitis G virus infection. Higher rates of the hepatitis G virus RNA and similar prevalence of anti-E2 in patients with renal failure as compared to controls suggest that the rate of hepatitis G virus infection resolution in immunosuppressed patients with renal failure might be lower than in immunocompetent subjects.",
author = "A. Szab{\'o} and U. Heemann and V. M{\"u}ller and G. Reusz and P. Sallay and S. Viazov and T. Tulassay",
year = "1999",
month = "7",
day = "18",
language = "Hungarian",
volume = "140",
pages = "1619--1623",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "29",

}

TY - JOUR

T1 - Hepatitis G vírus infekció vesetranszplantált és dializált gyermek és felnött betegekben.

AU - Szabó, A.

AU - Heemann, U.

AU - Müller, V.

AU - Reusz, G.

AU - Sallay, P.

AU - Viazov, S.

AU - Tulassay, T.

PY - 1999/7/18

Y1 - 1999/7/18

N2 - Recently, a new human virus hepatitis G virus was identified. The aim of the present study was to use a combination of the reverse transcription-polymerase chain reaction and a new test for antibodies to the viral envelope protein E2 to assess the prevalence of hepatitis G virus infection in sera of children and adults treated with hemodialysis or peritoneal dialysis as well as in sera of those who underwent renal transplantation. Hepatitis G virus RNA prevalence was higher in the shole group of patients with renal failure than in control group. The difference between hepatitis RNA prevalence in transplanted group and in control group was found to be significant. Anti-E2, which are is considered as an indicator of a past hepatitis G virus infection, were detected in the similar rate in the treated and control subjects. Time on hemodialysis was significantly longer in hepatitis G virus infected patients as compared to uninfected patients and all patients with hepatitis G virus RNA have a history of blood transfusions. Patients with renal failure treated with dialysis or subjected to renal transplantation are at increased risk of acquiring the hepatitis G virus infection. Higher rates of the hepatitis G virus RNA and similar prevalence of anti-E2 in patients with renal failure as compared to controls suggest that the rate of hepatitis G virus infection resolution in immunosuppressed patients with renal failure might be lower than in immunocompetent subjects.

AB - Recently, a new human virus hepatitis G virus was identified. The aim of the present study was to use a combination of the reverse transcription-polymerase chain reaction and a new test for antibodies to the viral envelope protein E2 to assess the prevalence of hepatitis G virus infection in sera of children and adults treated with hemodialysis or peritoneal dialysis as well as in sera of those who underwent renal transplantation. Hepatitis G virus RNA prevalence was higher in the shole group of patients with renal failure than in control group. The difference between hepatitis RNA prevalence in transplanted group and in control group was found to be significant. Anti-E2, which are is considered as an indicator of a past hepatitis G virus infection, were detected in the similar rate in the treated and control subjects. Time on hemodialysis was significantly longer in hepatitis G virus infected patients as compared to uninfected patients and all patients with hepatitis G virus RNA have a history of blood transfusions. Patients with renal failure treated with dialysis or subjected to renal transplantation are at increased risk of acquiring the hepatitis G virus infection. Higher rates of the hepatitis G virus RNA and similar prevalence of anti-E2 in patients with renal failure as compared to controls suggest that the rate of hepatitis G virus infection resolution in immunosuppressed patients with renal failure might be lower than in immunocompetent subjects.

UR - http://www.scopus.com/inward/record.url?scp=0033581047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033581047&partnerID=8YFLogxK

M3 - Article

VL - 140

SP - 1619

EP - 1623

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 29

ER -